Boyu Qin
Fuxing Road 28#
Haidian, 100853, China
Haidian, 100853, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Insulinoma-associated Protein-1 as a Biomarker for Diagnosis of Small Cell Lung Cancer: A Meta-analysis.
Journal: Pakistan journal of medical sciences
Published: December 16, 2025
Correction: Study of epirubicin sustained-release chemoablation in tumor suppression and tumor microenvironment remodeling.
Journal: Frontiers in immunology
Published: October 05, 2025
Clinical outcomes of a quadruplet regimen (immunotherapy, chemotherapy, anti-angiogenic therapy) in non-small cell lung cancer with EGFR exon 20 insertion mutations: a case series.
Journal: AME case reports
Published: September 09, 2025
Thermal modulation enhances antitumour immunity and improves immunotherapy responses in lung cancer.
Thermal modulation enhances antitumour immunity and improves immunotherapy responses in lung cancer.
Journal: Discover oncology
Published: August 21, 2025
STING facilitates the development of radiation-induced lung injury via regulating the PERK/eIF2α pathway.
Journal: Translational lung cancer research
Published: July 24, 2024
Targeting NQO1 induces ferroptosis and triggers anti-tumor immunity in immunotherapy-resistant KEAP1-deficient cancers.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: June 11, 2024
Nomograms Predict PFS and OS for SCLC Patients After Standardized Treatment: A Real-World Study.
Journal: International journal of general medicine
Published: January 02, 2024
Recent advancements in Mg-based micromotors for biomedical and environmental applications.
Journal: Journal of materials chemistry. B
Published: December 06, 2023
Fecal methylated syndecan-2 (SDC2) testing for early screening of colorectal cancerous and precancerous lesions: A real-world retrospective study in China.
Journal: Cancer pathogenesis and therapy
Published: November 25, 2023
Synergistic effect of additional anlotinib and immunotherapy as second-line or later-line treatment in pancreatic cancer: A retrospective cohort study.
Journal: Cancer innovation
Published: October 12, 2023
Efficacy and safety of anti-PD-1 inhibitor versus anti-PD-L1 inhibitor in first-line treatment of extensive-stage small cell lung cancer: a multicenter retrospective study.
Journal: BMC cancer
Published: September 05, 2023
Last Updated: 09/26/2026